Literature DB >> 25769306

A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program.

Meghan A Baker, Tracy A Lieu, Lingling Li, Wei Hua, Yandong Qiang, Alison Tse Kawai, Bruce H Fireman, David B Martin, Michael D Nguyen.   

Abstract

The Postlicensure Rapid Immunization Safety Monitoring Program, the vaccination safety monitoring component of the US Food and Drug Administration's Mini-Sentinel project, is currently the largest cohort in the US general population for vaccine safety surveillance. We developed a study design selection framework to provide a roadmap and description of methods that may be utilized to evaluate potential associations between vaccines and health outcomes of interest in the Postlicensure Rapid Immunization Safety Monitoring Program and other systems using administrative data. The strengths and weaknesses of designs for vaccine safety monitoring, including the cohort design, the case-centered design, the risk interval design, the case-control design, the self-controlled risk interval design, the self-controlled case series method, and the case-crossover design, are described and summarized in tabular form. A structured decision table is provided to aid in planning of future vaccine safety monitoring activities, and the data components comprising the structured decision table are delineated. The study design selection framework provides a starting point for planning vaccine safety evaluations using claims-based data sources.
© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Mini-Sentinel; PRISM; immunization; methods; safety; surveillance; vaccine

Mesh:

Substances:

Year:  2015        PMID: 25769306     DOI: 10.1093/aje/kwu322

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Vaccine Case-Population: A New Method for Vaccine Safety Surveillance.

Authors:  Hélène Théophile; Nicholas Moore; Philip Robinson; Bernard Bégaud; Antoine Pariente
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

2.  Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.

Authors:  Roger Baxter; Edwin Lewis; Kristin Goddard; Bruce Fireman; Nandini Bakshi; Frank DeStefano; Julianne Gee; Hung Fu Tseng; Allison L Naleway; Nicola P Klein
Journal:  Clin Infect Dis       Date:  2016-09-01       Impact factor: 9.079

3.  Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010-2018.

Authors:  Tara C Anderson; Jessica W Leung; Rafael Harpaz; Kathleen L Dooling
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

4.  Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.

Authors:  Dongwon Yoon; Ji-Ho Lee; Hyesung Lee; Ju-Young Shin
Journal:  BMJ       Date:  2021-01-29

Review 5.  Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.

Authors:  Lana Yh Lai; Faaizah Arshad; Carlos Areia; Thamir M Alshammari; Heba Alghoul; Paula Casajust; Xintong Li; Dalia Dawoud; Fredrik Nyberg; Nicole Pratt; George Hripcsak; Marc A Suchard; Dani Prieto-Alhambra; Patrick Ryan; Martijn J Schuemie
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

6.  A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study Protocol.

Authors:  Norazida Ab Rahman; Ming Tsuey Lim; Fei Yee Lee; Su Miin Ong; Kalaiarasu M Peariasamy; Sheamini Sivasampu
Journal:  Front Pharmacol       Date:  2022-07-13       Impact factor: 5.988

7.  Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network.

Authors:  John G Connolly; Shirley V Wang; Candace C Fuller; Sengwee Toh; Catherine A Panozzo; Noelle Cocoros; Meijia Zhou; Joshua J Gagne; Judith C Maro
Journal:  Curr Epidemiol Rep       Date:  2017-10-06

8.  Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque.

Authors:  Udo Hoffmann; Tomas G Neilan; Zsofia D Drobni; Raza M Alvi; Jana Taron; Amna Zafar; Sean P Murphy; Paula K Rambarat; Rayma C Mosarla; Charlotte Lee; Daniel A Zlotoff; Vineet K Raghu; Sarah E Hartmann; Hannah K Gilman; Jingyi Gong; Leyre Zubiri; Ryan J Sullivan; Kerry L Reynolds; Thomas Mayrhofer; Lili Zhang
Journal:  Circulation       Date:  2020-10-02       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.